"Parkinson’s dementia: down to earth answers for navigating the road ahead" by Prof. Rimona Weil

1. How Common is Dementia in Parkinson’s?
While cognitive change is a sensitive topic, understanding it is essential for preparation.
Research indicates that dementia is approximately six times more common in people with Parkinson’s than in the general population.
Longitudinal studies have shown that nearly 50% of people newly diagnosed with Parkinson’s may develop cognitive involvement within ten years.
However, there is significant variability; some individuals live with Parkinson's for many years without encountering cognitive issues.

2. Identifying the Signs: Parkinson’s vs. Alzheimer’s
It is important to distinguish Parkinson’s dementia from other conditions:
Primary Domains: In Parkinson’s, the main changes typically involve visuospatial processing (e.g., difficulty organizing items in space, navigating a mobile phone, or driving) and executive function (e.g., planning, multitasking, or managing finances).
Contrast with Alzheimer’s: Alzheimer’s primarily affects memory, often characterised by repeating questions or failing to recognise relatives—symptoms that are generally not dominant features in early Parkinson’s dementia.
"Brain Fog" is Normal: Walking into a room and forgetting why, or having a word on the "tip of your tongue," is often a normal sign of aging (especially over 40) and does not necessarily indicate dementia.

3. The Role of Vision in Prediction
Professor Weil’s research at UCL focuses on using vision tests as a predictive tool:
The Cat/Dog Test: Studies showed that people who struggle to distinguish distorted images of cats and dogs were more likely to show a decline in cognitive scores when followed over time.
Brain Connections: Advanced MRI techniques (pixel-based analysis) reveal that those at higher risk for dementia show a loss of "white matter integrity"—the connections between brain cells—long before traditional brain shrinkage is visible.

4. Taking Charge: What You Can Do Now
Professor Weil advocates for a "360-degree approach" to brain health, likening it to the "marginal gains" philosophy used by Olympic cycling coaches—making many small changes to achieve a significant impact.
Exercise, Exercise, Exercise: This is the intervention with the strongest evidence. Aim for 30 minutes, five times a week, mixing aerobic, strength, and posture work.

Social Interaction: Staying socially engaged—through work, hobbies, or community events—invokes complex brain networks that help maintain cognitive health.

Sensory Management: Treat cataracts and use hearing aids if needed. Managing hearing and vision loss is a proven way to reduce dementia risk.

Medical Solutions: If early cognitive changes are detected, "cholinesterase inhibitors" (such as Rivastigmine or Donepezil) can help boost acetylcholine levels and have been shown to keep cognition stable over several years in related conditions.

5. The Future: Disease-Modifying Treatments
There is growing optimism regarding treatments currently in the pipeline:
Anti-Amyloid Treatments: Drugs designed to remove amyloid proteins from the brain (already showing progress in Alzheimer's research) may eventually be tested for Parkinson's dementia.
Anti-Inflammatory Drugs: New compounds like Neflimapimod are being trialled to target inflammatory processes in the brain, offering a more tangible hope for slowing decline.
Conclusion: While Parkinson’s dementia is a challenging topic, Professor Weil emphasises that we are moving toward a future where we can detect individual risks early and provide targeted treatments. In the meantime, focusing on exercise, social connection, and proactive clinical management remains the best "offensive game" for patients and carers.